Featured Research

from universities, journals, and other organizations

Challenges of visual accessibility for people with low vision

Date:
June 24, 2014
Source:
Wolters Kluwer Health: Lippincott Williams and Wilkins
Summary:
New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world,” according to experts. Low vision is defined as chronically impaired vision that is not correctable by glasses or contact lenses and adversely affects everyday functioning. It is estimated that there are between 3.5 million and 5 million Americans with low vision, and this number is expected to increase as the population ages.

New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according to the review by Gordon E. Legge, PhD, of University of Minnesota. In recognition of his pioneering work on low-vision research and visual accessibility, Dr. Legge was named the 2013 Charles F. Prentice Award Lecture Medalist.

Visual Accessibility for People with Low Vision -- Challenges and New Approaches

Low vision is defined as chronically impaired vision that is not correctable by glasses or contact lenses and adversely affects everyday functioning. It is estimated that there are between 3.5 million and 5 million Americans with low vision, and this number is expected to increase as the population ages.

In his Prentice Lecture, Dr. Legge -- himself a person with low vision -- proposes to "embed low-vision research more explicitly in the real world" in order to reduce barriers to visual accessibility. He shares examples of his research in two key areas: architectural accessibility and reading accessibility.

Architectural design can enhance visual accessibility for people with low vision. Dr. Legge gives illustrated examples of how low vision can make it difficult to navigate architectural spaces; the obstacles and hazards may even change with the light at different times of day.

His research includes the development of software tools to promote the design of visually accessible spaces. These tools help in representing the impact of reduced visual acuity and contrast sensitivity, as well as predicting whether architectural features can be seen by people with low vision. Dr. Legge writes, "We need practical models of low vision capable of predicting real-world object visibility."

Dr. Legge's work also includes efforts to increase reading accessibility for people with low vision. Advances such as electronic readers provide powerful new tools to improve reading accessibility, but there's still a lack of knowledge of how best to use the features they provide. Research is needed to understand the interacting effects of variables such as display geometry, visual acuity, viewing distance, print size, and font.

Dr. Legge urges low-vision researchers to work with other disciplines -- including software and hardware developers and design professionals -- toward solving the problems of visual accessibility. He writes, "Where we succeed, we will contribute to vision science by showing how vision functions in the real world, and we will find better ways to reduce barriers facing people with visual impairment."

For his outstanding history of insights and research in the field of low vision, Dr. Legge was named winner of the American Academy of Optometry's Charles F. Prentice Medal for 2013. Established in 1958, the Charles F. Prentice Medal is awarded annually to an outstanding scientist who has contributed significantly to the advancement of knowledge in the visual sciences.

"Visual accessibility makes an environment, device, or display useable by those with low vision, comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science. "Our Prentice medalist is a world research leader in low vision and he gives us clear insight into the ways vision science plays an important role in enhancing visual accessibility for people with low vision."


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams and Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gordon E. Legge. Prentice Medal Lecture 2013. Optometry and Vision Science, 2014; 91 (7): 696 DOI: 10.1097/OPX.0000000000000310

Cite This Page:

Wolters Kluwer Health: Lippincott Williams and Wilkins. "Challenges of visual accessibility for people with low vision." ScienceDaily. ScienceDaily, 24 June 2014. <www.sciencedaily.com/releases/2014/06/140624105044.htm>.
Wolters Kluwer Health: Lippincott Williams and Wilkins. (2014, June 24). Challenges of visual accessibility for people with low vision. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2014/06/140624105044.htm
Wolters Kluwer Health: Lippincott Williams and Wilkins. "Challenges of visual accessibility for people with low vision." ScienceDaily. www.sciencedaily.com/releases/2014/06/140624105044.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins